Our results are in line with the findings of Simon et al. (Simon et al. 2005), who compared the validity of plasma apoB, non-HDL cholesterol and LDL-C in predicting cardiovascular risk, and subclinical atherosclerosis. The gene discussed is APOB; the disease is atherosclerosis.